New Cognitive and Social Therapies Show Promise for Schizophrenia, Yet Access Remains Limited

Schizophrenia ranks among the world’s top ten causes of disability, yet most patients experience persistent cognitive and social difficulties that are often overlooked. Over the past fifteen years, research has produced behavioral treatments—cognitive remediation and social cognitive training—that improve memory, attention, problem‑solving, and the ability to read others’ emotions. More than 100 controlled trials demonstrate these therapies enhance daily functioning. However, a 2025 WHO report indicates that roughly two‑thirds of people with schizophrenia worldwide receive no specialized mental health care, and few treatment centers have the expertise or resources to deliver these intensive programs. Without broader access, gains in quality of life and independence remain limited.